Spatial omics
AI co-pilot for academic research
AI biomarker discovery
AI target discovery
AI drug positioning
Next generation AI Dx
Powering precision pathology
We work with partners to apply AI to rich, multimodal data
Multimodal approach to biomarker identification
Using AI to match a drug/asset with new indication(s) or subpopulations of existing indications
Optimize ADCs with multimodal data and AI
Applying AI to multimodal data to identify the best candidate targets in a given indication
We select data-driven prognostic covariates for adjustment to broaden the eligibility criteria without sacrificing power of randomized control trials
Building external control arms from high-quality patient data
Derisk and accelerate your clinical trials
Matching drugs to patients in clinical trials and in clinical routine
MSIntuit® CRC is an AI diagnostic that provides a screening approach with digital pathology
An AI diagnostic to help pathologists and oncologists assess the risk of relapse of early breast cancer patients
A pre-screening tool to determine the status of TLS in a research setting
Fuel breakthroughs in oncology with spatial omics
Get closer to our science
